Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Inewme
- ·The full record, as it builds
Funding rounds
No funding rounds for Inewme are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Inewme
Manufacturer of skincare products intended for protective and personalized care purpose. The company offers medical-grade detection methods, cloud-based consultation services, and integration with cosmetic and healthcare applications, enabling consumers in the beauty and medical technology market to access personalized diagnostics, preventive care insights, and scientifically validated solutions that improve long-term skin health, support individualized treatment pathways, and foster reliable communication between users and professional institutions.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shenzhen, China
- Founded
- 2023
- Website
- inewme.com/
- Ownership
- Privately Held (backing)
Inewme doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Inewme shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Inewme in its N-PORT filings yet. We sweep new filings monthly.